(+39) 075 851 2197 – export@topqualitygroup.it

A case study on Vagy Combi, TQG’s leading device at IMCAS World Congress 2023

IMCAS World Congress is about to start. The international event will host over 14,000 people and more than 700 specialists will take turns on stage to present themes and works related to aesthetic and functional medicine. On January 26th, at 10.36 am, Dr. Stefano Berardi will give a report in front of the audience of IMCAS World Congress 2023 entitled “The treatment for vulvovaginal atrophy symptoms in breast cancer patients under tamoxifen therapy: is the Radio Frequency – Electroporation synergy a good option?”.

The focus of his work is on treating vulvovaginal atrophy (VVA) through Vagy Combi. VVA is a chronic progressive disease involving the female genital tract and lower urinary tract. The main purpose of this study is to report evidence regarding the efficacy and safety of radiofrequency and electroporation as an effective therapeutic choice for urogenital diseases in women with vulvovaginal atrophy in a specific context of a cancer patient.

We are waiting for you in Paris, at the Palais des Congrès, on 26-27-28 January for IMCAS World Congress 2023.

For more information about the event, CLICK HERE